cyclosporine has been researched along with Angor Pectoris in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Klaver, PAG; van den Wall Bake, AWL; van Sloten, TT | 1 |
Calabrese, S; Sparacino, V | 1 |
Koss-Harnes, D; Langeland, T; Ovrum, E | 1 |
3 other study(ies) available for cyclosporine and Angor Pectoris
Article | Year |
---|---|
Co-administration of cyclosporine and ticagrelor may lead to a higher exposure to cyclosporine: a case report of a 49-year-old man.
Topics: Adenosine; Angina Pectoris; Area Under Curve; ATP Binding Cassette Transporter, Subfamily B; Cyclosporine; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Graft Rejection; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Polypharmacy; Purinergic P2Y Receptor Antagonists; Ticagrelor | 2018 |
Conversion to a proliferation signal inhibitor in a patient with coronary artery disease--a case report.
Topics: Angina Pectoris; Angioplasty; Azathioprine; Calcineurin Inhibitors; Cell Proliferation; Cyclosporine; Drug Therapy, Combination; Everolimus; Female; Glucocorticoids; Humans; Immunosuppressive Agents; Kidney Transplantation; Middle Aged; Postoperative Complications; Signal Transduction; Sirolimus; Treatment Outcome; Withholding Treatment | 2006 |
Pyoderma gangrenosum as a complication of coronary artery bypass grafting.
Topics: Angina Pectoris; Biopsy; Coronary Artery Bypass; Cyclosporine; Diagnosis, Differential; Humans; Male; Middle Aged; Pyoderma Gangrenosum; Saphenous Vein; Sternum; Surgical Wound Infection; Wound Healing | 1995 |